Burning Rock Biotech (BNR) Treasury Shares (2022 - 2024)
Historic Treasury Shares for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to -$8.0 million.
- Burning Rock Biotech's Treasury Shares rose 1444.09% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year increase of 1444.09%. This contributed to the annual value of $8.7 million for FY2024, which is 661.57% down from last year.
- As of Q3 2025, Burning Rock Biotech's Treasury Shares stood at -$8.0 million, which was up 1444.09% from -$8.5 million recorded in Q2 2025.
- Burning Rock Biotech's Treasury Shares' 5-year high stood at $9.3 million during Q4 2023, with a 5-year trough of -$9.4 million in Q3 2024.
- Over the past 5 years, Burning Rock Biotech's median Treasury Shares value was -$8.3 million (recorded in 2022), while the average stood at -$3.9 million.
- Per our database at Business Quant, Burning Rock Biotech's Treasury Shares surged by 10272.31% in 2022 and then tumbled by 5010555.56% in 2023.
- Over the past 5 years, Burning Rock Biotech's Treasury Shares (Quarter) stood at -$661000.0 in 2021, then surged by 1392.28% to $8.5 million in 2022, then grew by 8.65% to $9.3 million in 2023, then dropped by 6.62% to $8.7 million in 2024, then plummeted by 192.7% to -$8.0 million in 2025.
- Its last three reported values are -$8.0 million in Q3 2025, -$8.5 million for Q2 2025, and -$8.6 million during Q1 2025.